• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Can Siemens Healthineers (XTRA:SHL) Justify Its Valuation After The Paradromics Collaboration?

    Simply Wall St·10/27/2026 11:21:02
    Listen to the news

    Siemens Healthineers (XTRA:SHL) is back in focus after Paradromics announced a collaboration to build multimodal imaging workflows for implantable brain-computer interfaces, targeting speech, motor and broader neurosurgical applications.

    Recent trading suggests interest is picking up in Siemens Healthineers, with the share price at €42.29, a 90 day share price return of 17.73% and a 30 day gain of 11.91%, even though the year to date share price return is down 4.19% and the 1 year total shareholder return is down 12.48%.

    Scan the neurotech opportunity set around Siemens Healthineers by reviewing a curated mix of healthcare and AI players in our 123 healthcare AI stocks that are already building toward similar clinical workflows.

    The Siemens Healthineers share price has sprinted ahead on BCI excitement and now sits closer to analyst targets. Does the current valuation still compensate you for the operational and share price setbacks of the past few years?

    Most Popular Narrative: 7% Undervalued

    On the most followed view, Siemens Healthineers screens as undervalued, with a fair value of €45.57 against the latest close at €42.29, even after the recent brain computer interface driven rebound.

    Strong, ongoing innovation in advanced imaging and AI-driven diagnostic solutions is now reflected in an equipment book-to-bill of 1.27. Photon-counting CT already represents roughly 30% of total CT equipment order volume and supports future revenue and earnings from a higher value mix.

    See why 40 investors see Siemens Healthineers as 7% undervalued.

    Result: Fair Value of €45.57 (UNDERVALUED)

    Still, the Siemens Healthineers story can break if Diagnostics keeps dragging on margins, or if inflation and tariffs erode profitability faster than expected.

    Find out about the key risks to this Siemens Healthineers narrative.

    Next Steps

    If the mixed signals around Siemens Healthineers leave you on the fence, act while the market narrative is still forming. Weigh both sides of the story and stress test your own thesis using the 3 key rewards and 1 important warning sign.

    Want more ideas beyond Siemens Healthineers?

    Do not stop with a single stock. Use the Simply Wall Street Screener to pressure test your current holdings and uncover fresh ideas that fit your style.